Andrographolide could inhibit human colorectal carcinoma Lovo cells migration and invasion via down-regulation of MMP-7 expression

Chemico-Biological Interactions

Volumn 180, Issue 3, 2009, Pages 344-352

  Shi, Ming Der ^a,b   Lin, Hui Hsuan ^c   Chiang, Tai An ^d   Tsai, Li Yu ^b   Tsai, Shu Mei ^d   Lee, Yi Chieh ^e   Chen, Jing Hsien ^d  

^a Yongkang Veterans Hospital   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

^e Institute of Biomedical Science   (Taiwan)

Author keywords

Andrographolide; Human colorectal carcinoma; Invasion; Metalloproteinase; Migration

Indexed keywords

ANDROGRAPHOLIDE; GELATINASE A; GELATINASE B; MATRILYSIN; TRANSCRIPTION FACTOR AP 1;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL INVASION; CELL MIGRATION; COLORECTAL CARCINOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; GENE EXPRESSION; HUMAN; HUMAN CELL; METASTASIS INHIBITION; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION;

ANDROGRAPHIS; ANTINEOPLASTIC AGENTS; CARCINOMA; CELL MOVEMENT; COLORECTAL NEOPLASMS; DITERPENES; DOWN-REGULATION; HERBAL MEDICINE; HUMANS; MATRIX METALLOPROTEINASE 7; NEOPLASM INVASIVENESS; TRANSCRIPTION FACTOR AP-1; TUMOR CELLS, CULTURED;

ANDROGRAPHIS PANICULATA;

EID: 67349194249     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2009.04.011     Document Type: Article

References (47)

1. Zhao J., Yang G., Liu H., Wang D., Song X., and Chen Y. Determination of andrographolide, deoxyandrographolide and neoandrographolide in the Chinese herb Andrographis paniculata by micellar electrokinetic capillary chromatography. Phytochem. Anal. 13 (2002) 222-227
2. Shen Y.C., Chen C.F., and Chiou W.F. Andrographolide prevents oxygen radical production by human neutrophils: possible mechanism(s) involved in its anti-inflammatory effect. Br. J. Pharmacol. 135 (2002) 399-406
3. Shen Y.C., Chen C.F., and Chiou W.F. Suppression of rat neutrophil reactive oxygen species production and adhesion by the diterpenoid lactone andrographolide. Planta Med. 66 (2000) 314-317
4. Xia Y.F., Ye B.Q., Li Y.D., Wang J.G., He X.J., Lin X., Yao X., Ma D., Slungaard A., Hebbel R.P., Key N.S., and Geng J.G. Andrographolide attenuates inflammation by inhibition of NF-kappa B activation through covalent modification of reduced cysteine 62 of p50. J. Immunol. 173 (2004) 4207-4217
5. Amroyan E., Gabrielian E., Panossian A., Wikman G., and Wagner H. Inhibitory effect of andrographolide from Andrographis paniculata on PAF-induced platelet aggregation. Phytomedicine 6 (1999) 27-31
6. Shukla B., Visen P.K.S., Patnaik G.K., and Dhawan B.N. Choleretic effect of andrographolide in rats and guinea pigs. Planta Med. 58 (1992) 146-149
7. Trivedi N.P., Rawal U.M., and Patel B.P. Hepatoprotective effect of andrographolide against hexachlorocyclohexane-induced oxidative injury. Integr. Cancer Ther. 6 (2007) 271-280
8. Basak A., Cooper S., Roberge A.G., Banik U.K., Chretien M., and Seidah N.G. Inhibition of proprotein convertases-1, -7 and furin by diterpenes of Andrographis paniculata and their succinoyl esters. Biochem. J. 338 (1999) 107-113
9. Reddy V.L., Reddy S.M., Ravikanth V., Krishnaiah P., Goud T.V., Rao T.P., Ram T.S., Gonnade R.G., Bhadbhade M., and Venkateswarlu Y. A new bis-andrographolide ether from Andrographis paniculata Nees and evaluation of anti-HIV activity. Nat. Prod. Res. 19 (2005) 223-230
10. Rajagopal S., Ajaya K.R., Devi D.S., Satyanarayana C., and Rajagopalan R. Andrographolide, a potential cancer therapeutic agent isolated from Andrographis paniculata. J. Exp. Ther. Oncol. 3 (2003) 147-158
11. Srinivasa R.J., Hamzah A.S., Saad M.S., Lajis N.H., Stevens M.F.G., and Stanslas J. Semisynthesis and cytotoxic activities of andrographolide analogues. J. Enzyme Inhib. Med. Chem. 21 (2006) 145-155
12. Shi M.D., Lin H.H., Lee Y.C., Chao J.K., Lin R.A., and Chen J.H. Inhibition of cell-cycle progression in human colorectal carcinoma Lovo cells by andrographolide. Chem. Biol. Interact. 174 (2008) 201-210
13. Zhou J., Zhang S., Ong C.N., and Shen H.M. Critical role of pro-apoptotic Bcl-2 family members in andrographolide-induced apoptosis in human cancer cells. Biochem. Pharmacol. 72 (2006) 132-144
14. Sheeja K., and Kuttan G. Activation of cytotoxic T lymphocyte responses and attenuation of tumor growth in vivo by Andrographis paniculata extract and andrographolide. Immunopharmacol. Immunotoxicol. 29 (2007) 81-93
15. Tsai H.R., Yang L.M., Tsai W.J., and Chiou W.F. Andrographolide acts through inhibition of ERK1/2 and Akt phosphorylation to suppress chemotactic migration. Eur. J. Pharmacol. 498 (2004) 45-52
16. Fidler I.J. The organ microenvironment and cancer metastasis. Differentiation 70 (2005) 498-505
17. Parks W.C., and Shapiro S.D. Matrix metalloproteinases in lung biology. Respir. Res. 2 (2001) 10-19
18. Zucker S., and Vacirca J. Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev. 23 (2004) 101-117
19. Adachi Y., Yamamoto H., Itoh F., Hinoda Y., Okada Y., and Imai K. Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers. Gut 45 (1999) 252-258
20. Aguirre Ghiso J.A., Alonso D.F., Farias E.F., Gomez D.E., and de Kier Joffe E.B. Deregulation of the signaling pathways controlling urokinase production. Its relationship with the invasive phenotype. Eur. J. Biochem. 263 (1999) 295-304
21. Westermarck J., and Kahari V.M. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 13 (1999) 781-792
22. Himelstein B.P., Canete-Soler R., Bernhard E.J., and Muschel R.J. Induction of fibroblast 92 kDa gelatinase/type IV collagenase expression by direct contact with metastatic tumor cells. J. Cell Sci. 107 (1994) 477-486
23. Garbisa S., Sartor L., Biggin S., Salvato B., Benelli R., and Albini A. Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate. Cancer 91 (2001) 822-832
24. Purcell W.T., Rudek M.A., and Hidalgo M. Development of matrix metalloproteinase inhibitors in cancer therapy. Hematol. Oncol. Clin. North Am. 16 (2002) 1189-1227
25. Bloomston M., Zervos E.E., and Rosemurgy II A.S. Matrix metalloproteinases and their role in pancreatic cancer: a review of preclinical studies and clinical trials. Ann. Surg. Oncol. 9 (2002) 668-674
26. Sheeja K., Guruvayoorappan C., and Kuttan G. Antiangiogenic activity of Andrographis paniculata extract and andrographolide. Int. Immunopharmacol. 7 (2007) 211-221
27. Alley M.C., Scudiero D.A., Monks A., Hursey M.L., Czerwinski M.J., Fine D.L., Abbott B.J., Mayo J.G., Shoemaker R.H., and Boyd M.R. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 48 (1988) 589-601
28. Zhang G., Dass C.R., Sumithran E., Di Girolamo N., Sun L.Q., and Khachigian L.M. Effect of deoxyribozymes targeting c-Jun on solid tumor growth and angiogenesis in rodents. J. Natl. Cancer Inst. 96 (2004) 683-696
29. Attiga F.A., Fernandez P.M., Weeraratna A.T., Manyak M.J., and Patierno S.R. Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases. Cancer Res. 60 (2000) 4629-4637
30. Chu S.C., Chiou H.L., Chen P.N., Yang S.F., and Hsieh Y.S. Silibinin inhibits the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. Mol. Carcinog. 40 (2004) 143-149
31. Barille S., Bataille R., Rapp M.J., Harousseau J.L., and Amiot M. Production of metalloproteinase-7 (matrilysin) by human myeloma cells and its potential involvement in metalloproteinase-2 activation. J. Immunol. 163 (1999) 5723-5728
32. Chen J.H., Tseng T.H., Ho Y.C., Lin H.H., Lin W.L., and Wang C.J. Gaseous nitrogen oxides stimulate cell cycle progression by Rb-phosphorylation via activation of cyclins/cdks. Toxicol. Sci. 76 (2003) 83-90
33. Ho E., and Ames B.N. Low intracellular zinc induces oxidative DNA damage, disrupts p53, NFkappa B, and AP1 DNA binding, and affects DNA repair in a rat glioma cell line. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 16770-16775
34. Chakraborti S., Mandal M., Das S., Mandal A., and Chakraborti T. Regulation of matrix metalloproteinases: an overview. Mol. Cell Biochem. 253 (2003) 269-285
35. Satyanarayana C., Deevi D.S., Rajagopalan R., Srinivas N., and Rajagopal S. DRF 3188 a novel semi-synthetic analog of andrographolide: cellular response to MCF 7 breast cancer cells. BMC Cancer 4 (2004) 26-33
36. Cheung H.Y., Cheung S.H., Li J., Cheung C.S., Lai W.P., Fong W.F., and Leung F.M. Andrographolide isolated from Andrographis paniculata induces cell cycle arrest and mitochondrial-mediated apoptosis in human leukemic HL-60 cells. Planta Med. 71 (2005) 1106-1111
37. Kim Y.S., and Milner J.A. Targets for indole-3-carbinol in cancer prevention. J. Nutr. Biochem. 16 (2005) 65-73
38. Rudolph-Owen L.A., Chan R., Muller W.J., and Matrisian L.M. The matrix metalloproteinase matrilysin influences early stage mammary tumorigenesis. Cancer Res. 58 (1998) 5500-5506
39. Wilson C.L., Heppner K.J., Labosky P.A., Hogan B.L.M., and Matrisian L.M. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc. Natl Acad. Sci. U.S.A. 94 (1997) 1402-1407
40. Newell K.J., Witty J.P., Rodgers W.H., and Matrisian L.M. Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis. Mol. Carcinog. 10 (1994) 199-206
41. Hasegawa S., Koshikawa N., Momiyama N., Moriyama K., Ichikawa Y., Ishikawa T., Mitsuhashi M., Shimada H., and Miyazaki K. Matrilysin-specific antisense oligonucleotide inhibits liver metastasis of human colon cancer cells in a nude mouse model. Int. J. Cancer 76 (1998) 812-816
42. Witty J.P., McDonnell S., Newell K.J., Cannon P., Navre M., Tressler R.J., and Matrisian L.M. Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo. Cancer Res. 54 (1994) 4805-4812
43. Yamamoto H., Itoh F., Senota A., Adachi Y., Yoshimoto M., Endoh T., Hinoda Y., Yachi A., and Imai K. Expression of matrix metalloproteinase matrilysin (MMP-7) was induced by activated Ki-ras via AP-1 activation in SW1417 colon cancer cells. J. Clin. Lab. Anal. 9 (1995) 297-301
44. Kim M., Murakami A., Kawabata K., and Ohigashi H. (-)-Epigallocatechin-3-gallate promotes pro-matrix metalloproteinase-7 production via activation of the JNK1/2 pathway in HT-29 human colorectal cancer cells. Carcinogenesis 26 (2005) 1553-1562
45. Leupold J.H., Asangani I., Maurer G.D., Lengyel E., Post S., and Allgayer H. Src induces urokinase receptor gene expression and invasion/intravasation via activator protein-1/p-c-Jun in colorectal cancer. Mol. Cancer Res. 5 (2007) 485-496
46. Bergman M.R., Cheng S., Honbo N., Piacentini L., Karliner J.S., and Lovett D.H. A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimers. Biochem. J. 369 (2003) 485-496
47. Philip S., and Kundu G.C. Osteopontin induces nuclear factor kappa B mediated promatrix metalloproteinase-2 activation through I kappa B alpha/IKK signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways. J. Biol. Chem. 278 (2003) 14487-14497